Evolving Strategies in Pulmonary Embolism: From Risk Stratification to Interventional Therapy
This expert-led, on-demand programme explores the latest evidence and interventional strategies for intermediate-high and high-risk pulmonary embolism (PE). Chaired by Prof Stavros Konstantinides (University of Mainz, Mainz, DE) and featuring renowned specialists Dr José Montero-Cabezas (Leiden University Medical Center, Leiden, NL), Dr Mario Iannaccone (Turin Nord Emergency Hospital, Turin, IT) and Dr Sylwia Sławek-Szmyt (Poznan University of Medical Sciences, Poznan, PL), this session delivers a comprehensive, clinically relevant update on the evolving landscape of PE care.
The session offers a comprehensive exploration of risk stratification and clinical decision-making in pulmonary embolism care. Gain clinical trial insights through an in-depth look at the STORM-PE and STRIKE-PE trials, examining their findings and how they shape current practice. A dedicated technology spotlight provides a detailed review of Computer Assisted Vacuum Thrombectomy (CAVT), followed by case-based learning that showcases real-world CAVT interventions, including technique considerations, clinical outcomes, and post-procedural care. The session concludes with an interactive panel discussion.
Learn at your own pace and access expert insights and real-world clinical examples.
Key Learning Objectives
- Understand the clinical presentation and risk stratification of intermediate-high and high- risk pulmonary embolism, with emphasis on indicators for escalation to advanced interventional therapies
- Evaluate current evidence and emerging clinical trial data, including STRIKE-PE and STORM- PE, supporting the use of Computer Assisted Vacuum Thrombectomy in the management of acute pulmonary embolism
- Review the technical considerations and procedural workflow of Computer Assisted Vacuum Thrombectomy including patient selection, access strategy and safety outcomes
- Apply real-world clinical experience through case-based learning, illustrating decision- making, procedural technique and post-procedural care in PE patients treated with catheter-based interventions
- Engage in multidisciplinary discussion to refine treatment strategies, enhance guideline- concordant care
Target Audience
- Interventional Cardiologists
- Interventional Radiologists
- Angiologists
- Intensive Care Unit
- General Cardiologists
- Pneumologists
More from this programme
Part 1
Welcome and Introduction
Prof Konstantinides provides a short overview and introduction to the webinar.
| 1 session | |
| Welcome and Introduction | Watch now |
Part 2
Risk-Adjusted Assessment: Who Needs Advanced Treatment?
Dr José Montero-Cabezas presents on distinguishing between intermediate-high vs high-risk PE patients, patient selection for advanced therapies, and the importance of the collaboration of PERT teams.
Part 3
Principles and Practice of Computer Assisted Vacuum Thrombectomy
Dr Mario Iannacone discusses Computer-Assisted Vacuum Thrombectomy (CAVT), using a a clinical presentation of a 71-year-old male.
Part 4
Evidence and Emerging Data
Prof Stavros Konstantinides provides an overview of STRIKE-PE and STORM-PE trial findings.
| 1 session | |
| Evidence and Emerging Data | Watch now |
Part 5
Clinical Application: Real-Life Case Series
Dr Sylwia Sławek-Szmyt shares two PE case studies treated with Computer Assisted Vacuum Thrombectomy.
Part 6
Panel Discussion & Audience Q&A
Prof Stavros Konstantinides chairs an engaging panel discussion, guiding an interactive session where key questions from the live audience are addressed.
| 1 session | |
| Panel Discussion & Audience Q&A | Watch now |
Faculty Biographies
Stavros Konstantinides
Professor for Clinical Trials and Medical Director of the Center for Thrombosis and Hemostasis
Prof Stavros Konstantinides, MD, FESC, is Professor for Clinical Trials and Medical Director of the Center for Thrombosis and Hemostasis (CTH) at the University of Mainz, Germany. He is also Professor of Cardiology at the Democritus University of Thrace, Greece. He graduated from the Aristotle University of Thessalonica, Greece, and earned his doctorate degree at the University of Freiburg, Germany.
For the past 35 years, his clinical and translational research has focused on the risk stratification and risk-adapted antithrombotic management of thrombosis and pulmonary embolism. He has designed and coordinated, and has been principal investigator of numerous high-impact national and international academically sponsored multicentre trials. He is leading member of national and European committees, task forces for clinical practice guidelines, and of networks on pulmonary circulation and right ventricular function.
Comments